Catalog name Description price
R-M2-10106 FITC-SS31 FITC-SS31 is a fluorescein labeled derivative of SS-31 peptide, specifically designed for mitochondrial targeting studies. Advantages: Non membrane potential dependent targeting, does not affect mitochondrial function measurement, suitable for live cells and in vivo experiments. Application scenarios: Observation of mitochondrial dynamics (such as targeted changes under stress). Efficacy evaluation of oxidative stress models (such as H ₂ O ₂, t-BHP treatment). Mechanism research on mitochondrial related diseases such as sepsis and neurodegenerative diseases. price>
R-M2-10111 Artesunate-PEG2k-SS-cRGDfk Artesunate-PEG2k-SS-CRGDFk is a bifunctional complex primarily used for tumor targeted therapy and drug delivery systems. Application fields: Tumor treatment: used for delivering chemotherapy drugs, gene drugs, or nucleic acid drugs to improve efficacy and reduce side effects. Drug delivery system: As a modification material for nanocarriers such as liposomes and polymer micelles, it enhances targeting and stability. price>
R-M1-8478 YIGSR-PEG-N3  The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice. price>
R-M1-8489 DMG-PEG-R8 DMG-PEG-R8,DMG-PEG-octaarginine for enhanced delivery of a bioactive molecule into cells. The PEG2K component may contribute to improved stability and solubility, while the R8 component may aid in cellular uptake. price>
R-M2-10124 E7(EPLQLKM)-peg-DMG E7(EPLQLKM)-peg-DMG/DMG-peg-E7(EPLQLKM)/-peg-DMG is an E7 derived peptide modified with PEG-DMG (di nutmeg glycerol polyethylene glycol), mainly used for targeted drug delivery and biological coupling research. Application: Targeted therapy: can be used in combination with chemotherapy drugs or siRNA for targeted therapy of HPV related tumors. Immune regulation: used in vaccine adjuvants or immunotherapy research, by activating the TLR pathway or regulating immune cell function. Biocoupling: As a connecting arm, it is used to construct peptide drug conjugates (PDCs) or nanocarriers. price>
R-M1-8491 CY5-PEG-iRGD CY5-PEG-iRGD is a compound designed for targeted delivery and imaging in cancer research. It consists of three components: CY5, a red fluorescent dye for visualization purposes; PEG, a biocompatible polymer that enhances stability and biocompatibility; and iRGD, a peptide sequence that specifically targets tumor cells. price>
R-M2-10126 DMG-GPQGIAGQR-PEG-CpG-ODN DMG-GPQGIAGQR-PEG-CpG-ODN is a CpG oligonucleotide modified with PEG and DMG, mainly used in vaccine adjuvant and immunotherapy research. Application: Vaccine adjuvant: can enhance the immunogenicity of vaccines and reduce antigen dosage. Immunotherapy: Used in combination with chemotherapy and radiotherapy to improve the tumor microenvironment. Mechanism research: Used to analyze the TLR9 signaling pathway and immune cell activation mechanism. price>
R-M2-10127 Chol-GPQGIAGQR-PEG-CpG-ODN Chol-GPQIAGQR-PEG-CpG-ODN/Cholesterol-GPQGIAGQR-PEG-CpG-ODN is a CpG oligonucleotide modified with cholesterol (Chol), GPQGIAGQR peptide, and PEG2000, mainly used in vaccine adjuvant and immunotherapy research. Application: Vaccine adjuvant: can enhance the immunogenicity of vaccines and reduce antigen dosage. Immunotherapy: Used in combination with chemotherapy and radiotherapy to improve the tumor microenvironment. Mechanism research: Used to analyze the TLR9 signaling pathway and immune cell activation mechanism. price>
R-M1-8496 mpeg2000-SFSHHTPILPLCK MPEG2000-SFSHHTPILPLCK is a peptide sequence composed of specific amino acids. price>
R-M1-8507 SH-PEG3.4k-Angiopep2(TFFYGGSRGKRNNFKTEEYC) SH-PEG3.4K-Angiopep2 is a linear heterobifunctional PEG reagent with thiol and Angiopep2 (TFFYGGSRGKRNNFKTEEYC). price>